Navigation Links
LifeNet Health Chief Scientific Officer Wins Award
Date:5/8/2008

VIRGINIA BEACH, Va., May 8 /PRNewswire-USNewswire/ -- LifeNet Health, a leading allograft bio-implant company announces that Lloyd Wolfinbarger, Jr., Ph.D., was awarded an Excellence in Innovation award at the 11th Annual Hampton Roads Technology Council's Tech Nite in Hampton, Virginia.

The Excellence in Innovation award, sponsored by Willcox and Savage, P.C., recognizes the most innovative patents that were filed from within the Hampton Roads region. Hampton Roads Technology Council considered approximately 170 patents and three winners were chosen out of 10 nominees. The awards were issued to Hampton Roads inventors that were deemed by a panel of experts to represent significant commercial potential and/or social benefit.

Dr. Wolfinbarger was awarded the Excellence in Innovation award for a patent on Bioreactor Mediated Recellularization of Natural and Tissue Engineered Vascular Grafts.

"We are honored to have Dr. Wolfinbarger leading our research efforts at LifeNet Health. His contributions to the tissue banking industry are helping to restore health to thousands of patients. Since LifeNet Health's beginning 25 years Dr. Wolfinbarger has played an integral part in our company's success. He is a leader in medicine and we're proud that the Hampton Roads Technology Council recognized his valuable contributions at Tech Nite," states Rony Thomas, LifeNet Health's CEO.

Tech Nite is an annual recognition event, organized by the Hampton Roads Technology Council, for high-tech companies, individuals, entrepreneurs, and innovations of the Hampton Roads region. The Hampton Roads Technology Council's (http://www.hrtc.org) mission is to accelerate the transformation of Hampton Roads and its technology firms into world-recognized technology leaders.

Dr. Wolfinbarger is the Chief Scientific Officer at LifeNet Health and his work has resulted in dozens of patents. He rece
'/>"/>

SOURCE LifeNet Health
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. LifeNet Health and IMS Announce Partnership
2. LifeNet Health and LOPA Announce a Partnership
3. LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007
4. LifeNet Health(R) Unveils New Biomedical Spine Implant
5. ETEX and LifeNet Health, Inc. Enter Agreement
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
11. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  Naldemedine, an investigational peripherally ... Shionogi & Co., Ltd., met its primary and ... I) for the treatment of opioid-induced constipation (OIC) ... opioid therapy. Study results showed that naldemedine (0.2 ... the frequency of spontaneous bowel movement (SBM) compared ...
(Date:3/29/2015)... 2015 Caris Life Sciences® today ... showing the presence of PD-1 and PD-L1 ... Using Caris Molecular Intelligence®, the company,s panomic ... of programmed cell death protein-1 (PD-1) in ... its ligand (PD-L1) expression was variable across ...
(Date:3/27/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that ... in accordance with Securities and Exchange Commission rule 10b5-1. ... Corporation, is a minority owner of this entity that ... Herbert does not have control of this entity, but ... for a portion of the shares owned by that ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
Breaking Biology Technology:Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6
... that the economy is not,only heading towards a recession ... mood during January. However, biotech held steady,with the Burrill ... which posted a January loss of 9.9%, and the ... to ride out extremely volatile capital,markets with less damage ...
... BODY WORLDS 2:,The Original Exhibition of Real Human ... Saturday, February 2nd. The acclaimed exhibition,includes the East ... special feature on,the brain., BODY WORLDS presents ... and unhealthy organs, body section and slices, all,preserved ...
... Pollard Brings the Highest Level of Clinical Immunology ... 1 Genetic,Immunity(R), a US/Hungarian clinical-stage biopharmaceutical company,focused ... platform technology, announced that it has appointed,Richard B. ... Pollard has been a leader in HIV/AIDS research ...
Cached Biology Technology:January Market Jitters Fails to Derail Biotech 2January Market Jitters Fails to Derail Biotech 3January Market Jitters Fails to Derail Biotech 4Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 2Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer 3
(Date:3/20/2015)... DUBLIN , Mar. 19, 2015 Research and Markets ... the "Iris Biometrics - Global Strategic Business Report" ... worldwide markets for Iris Biometrics in US$ Thousands. The report ... , Japan , Europe ... East , and Latin America . ...
(Date:3/17/2015)... 2015 Emotient, the leader in facial ... general availability of Emotient Analytics , the ... of facial expressions. The system analyzes videos of ... and services. It delivers audience response metrics - ... as derived from facial evidence of emotional states. ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... than 400 million years, the horseshoe crab is now ... destruction. However, climatic changes may,also play a role. Researchers ... crab populations are to natural climate change in a ... . The horseshoe crab is often regarded as ...
... release is available in German . , Tobias Brgmann ... I used a so-called "channelrhodopsin" for their experiments, which is a ... as an ion channel in the cell membrane. When stimulated with ... cell. This causes a change in the cell membrane,s pressure, which ...
... the poles almost everywhere in the world, except along ... snails Steffen Kiel and Sven Nielsen at the Christian-Albrechts-Universitt ... originated at the end of the last ice age, ... a mosaic landscape of countless islands, bays and fiords ...
Cached Biology News:Climate change affects horseshoe crab numbers 2Bonn researchers use light to make the heart stumble 2Disappearing glaciers enhanced biodiversity 2
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets USA ...
... 2 Detection System combines the indirect ... principle and Signets unique formulation of ... and reliablility. Signet reagents will achieve ... and automated protocols. ,Signets USA Detection ...
... Level 2 Detection System combines the ... bonding principle and Signets unique formulation ... specificity and reliablility. Signet reagents will ... manual and automated protocols. ,Signets ...
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
Biology Products: